Komori
Pharmarise Holdings (2796) · FactAddition of the Pharmaceutical Wholesale Business

Integration into the "Other" segment of the wholesale business

First written in FY2023-Q1. 2 of 4 entries say "Restated". Latest entry: FY2026.

4entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2023-Q1 – FY20262022: 120222023: 220232024: 020242025: 020252026: 12026
Same theme, other companies
Integration into the "Other" segment of the wholesale businessA theme 1 companies write about · 0 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026Addition of the Pharmaceutical Wholesale BusinessAnnual report

    「A new addition is the pharmaceutical wholesale business operated by 三幸メディカル株式会社.」

    The pharmaceutical wholesale business operated by 三幸メディカル has been newly added to the Other business.
  2. FY2023RestatedAnnual report

    「From the current consolidated fiscal year, wholesale transactions previously included within the "Dispensing Pharmacy Business" and "Merchandising Business" have been moved from the respective reporting segments into the "Other" segment.」

    The reporting classification that integrates wholesale transactions into the "Other" segment is also being applied for the full fiscal year.
  3. FY2023-Q3RestatedAnnual report

    「Beginning with the first quarter, the business segments presented as reportable segments have been changed, and comparisons and analysis for the cumulative third quarter of the current consolidated fiscal year are based on the revised classification.」

    The reporting segment classification under which wholesale transactions were integrated into the “Other” segment continues to be applied in the cumulative third quarter of the current fiscal year.
  4. FY2023-Q1First statedAnnual report

    「From the first quarter of the current fiscal year, wholesale transactions previously included within the dispensing pharmacy business and merchandise business have been integrated into the “Other” segment from the respective reporting segments. This follows a review of management decision-making and performance classifications, after which it was determined that separating these transactions from the existing segments was more appropriate.」

    Following a review of management decision-making and performance classifications, wholesale transactions were transferred from the dispensing pharmacy business and merchandise business to the “Other” segment.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Pharmarise Holdings's next results are scheduled for 2026-09-17. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Integration into the "Other" segment of the wholesale business | Pharmarise Holdings Corporation (2796) | Komori